跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Matairesinol
首页
药物
Matairesinol
Experimental
Small Molecule
Matairesinol
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
20
H
22
O
6
CAS 编号
580-72-3
UNII ID
XLW63P8WUA
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHOD FOR SEPARATING EIGHT COMPONENTS IN CHINESE TRADITIONAL MEDICINE COMPOSITION
EP 3705130 B1
申请人: SHIJIAZHUANG YILING PHARMACEUTICAL CO LTD
优先权: 2017
CN
EP
US
WO
5 件公开
Composition and method to treat and alleviate symptoms of hot flashes in a female subject
US 9669006 B2
申请人: U S NUTRACEUTICALS LLC D/B/A VALENSA INT
优先权: 2015
US
WO
4 件公开
Herbal chemical composition for the treatment of cancer
US 7285571 B2
申请人: COUNCIL SCIENT IND RES
优先权: 2001
US
4 件公开
Method for the preparation of enterolactone from matairesinol
US 2005038268 A1
申请人: SJOHOLM RAINER
优先权: 2002
US
WO
2 件公开
Pharmaceutical composition comprising wikstromol and/or mataires inal, its use as hepatoprotectant and process for their isolation from cedurs deodara
CN 1484528 A
申请人: COUNCIL SCIENT IND RES
优先权: 2000
CN
Use of two plant phenols in the treatment of arteriosclerosis
US 6458831 B1
申请人: COUNCIL SCIENT IND RES
优先权: 2000
US
Use of lignans in foods
US 2004156881 A1
申请人: CASSIDY AEDIN
优先权: 2001
US
Monocot seeds with increased lignan content
US 2002174452 A1
申请人: LEWIS NORMAN G
优先权: 2001
US
Method of inhibiting overactivity of phagocytes or lymphocytes in an individual
US 2003100514 A1
申请人: AHOTUPA MARKKU
优先权: 2001
US
Novel herbal chemical composition for treatment of cancer
CN 1582160 A
申请人: COUNCIL SCIENT IND RES
优先权: 2001
CN
第 1 / 3 页
上一页
下一页
药物
反馈